Brief: Mankind Pharma Q4 Consol Net Profit 4.21 Billion Rupees IBES Est. 3.60 Billion Rupees
21/05/2025 13:34
May 21 (Reuters) - Mankind Pharma Ltd MNKI.NS: Q4 CONSOL NET PROFIT 4.21 BILLION RUPEES; IBES EST. 3.60 BILLION RUPEES Q4 CONSOL REVENUE FROM OPERATIONS 30.79 BILLION RUPEES; IBES EST. 30.9 BILLION RUPEES Further company coverage: MNKI.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery